Ubs Asset Management Americas Inc Edgewise Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 279,125 shares of EWTX stock, worth $6.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
279,125
Previous 84,294
231.13%
Holding current value
$6.5 Million
Previous $2.25 Million
231.35%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EWTX
# of Institutions
216Shares Held
98.2MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$350 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$207 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$143 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$140 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$116 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.47B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...